Progression of Advance Infusion Systems in the US: Ken Research Advanced Infusion Systems are a category of devices used to administer liquid drugs into the patient’s circulatory system. One of the best ways to administer a drug into the patient’s system is through intravenous, although arterial, subcutaneous and epidural infusion is more favourable. Advanced Infusion Systems are widely used because of their dependable, ergonomic design and user-friendly characteristics. Originally, infusion systems are used for medication purpose but due to high death rates, advanced infusion systems are developed. According to the research report "United States Advanced Infusion Systems Market Research Report Forecast 2017 to 2022", in the United States there is an increase in aged population with diabetes, cancer and lifestyle diseases that has encouraged the development and growth in the advanced infusion systems market. Enormous developed technology in advanced infusion systems helps to eradicate userrelated risks, safety, therapeutic effectiveness, higher bioavailability, and increase in healthcare spending. These factors also boost in the growth of the advanced infusion systems market. The advanced infusion systems globally is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the largest regional segment in the global advanced infusion systems market and accounts for a larger share compared to the other regions. This is mainly due to a great number of people suffering from prolonged diseases, high prevalence of cancers and lifestyle diseases. The factors affecting the progress in the advanced infusion systems market in the USA are frequency of chronic diseases along with increasing aged population, consumers’ adoption of portable infusion systems to reduce hospital expenditure, and constant increase in surgical procedural numbers. In the USA, the advanced Infusion Pumps are majorly used for chemotherapy/oncology, gastroenterology, analgesia/pain management, diabetes, pediatrics/neonatology, hematology, and other applications. In the year 2015, there was a significant growth because the chemotherapy/oncology segment accounted for a larger share of the advanced infusion systems. The increasing occurrence of diabetes is coupled with the management of insulin at home thus, expecting a rapid growth of advance infusion systems market. The global advanced infusion systems and product type are divided based on Disposable Infusion System, Elastomeric Infusion System, Ambulatory Infusion System, Volumetric Infusion System, Patient Controlled Analgesia Pump, Syringe Infusion System and Implantable Infusion System. Clinical Nutrition, Chemotherapy, Pain Management, Diabetes and Asthma Treatment are the nature of the application types of the global advanced infusion systems. Globally the end-users of the advanced infusion systems are Hospitals, Ambulatory Surgical Centres, and Diagnostic Centres. The major players in the global advanced infusion pumps market are Becton, Dickinson and Company (U.S.), Baxter International, Inc. (U.S.), Pfizer Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius SE & CO. KGaA (Germany), Medtronic plc (Ireland), Smiths Group plc (U.K.), Terumo Corporation (Japan), Moog, Inc. (U.S.), F. Hoffmann-la Roche Ltd.(Switzerland), and Johnson & Johnson (U.S.). Hospira is a leading competitor in infusion technologies globally.
Progression of Advance Infusion Systems in the US: Ken Research
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.